You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 232 No. 4, April 28, 1975 TABLE OF CONTENTS
  JAMA
  •  Online Features
  ARTICLE
 This Article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA

Measles pneumonia. Bacterial suprainfection as a complicating factor

R. W. Olson and G. R. Hodges

During a 3 1/2-month period, 32 previously healthy young men were first seen typical prodromal symptoms and signs of measles. On admission or within 48 hours of admission, 16 patients (50%) manifested physical signs and roentgenographic evidence of pneumonia. Of these 16 patients, ten (63%) were found to have bacterial suprainfection or colonization confirmed by culture of transtracheal aspirates. From six of these ten patients, Neisseria meningitidis serogroup Y was isolated as the sole organism responsible for suprainfection. In the other patients, Haemophilus species, Neisseria species (not N gonorrheae or N meningitidis), Streptococcus pneumoniae, and beta-hemolytic Streptococcus (not group A or D were isolated alone or in combination. The data suggest that bacterial supra-infection associated with measles pneumonia is not unusual in adults and N meningitidis serogroup Y is a potential pathogen of the lower respiratory tract.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Meta-analysis of trials of prophylactic antibiotics for children with measles: inadequate evidence
Shann
BMJ 1997;314:334-334.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1975 American Medical Association. All Rights Reserved.